Research Directory

  1. Syphogen sees opportunities in antibody mixtures

    Tuesday 22 March 2011

    Interviewee/Contributer: Kirsten Drejer

    Organisation: Symphogen A/S

    Read more

  2. Capital efficiency -- a new norm

    Tuesday 22 March 2011

    Interviewee/Contributer: Werner Lanthaler

    Organisation: Evotec AG

    Read more

  3. A small molecule approach to inflammation: Chroma Therapeutics targets the macrophage

    Friday 18 February 2011

    Interviewee/Contributer: Ian Nicholson

    Organisation: Chroma Therapeutics Ltd

    Read more

  4. Securing Europe's lead in vaccine research

    Tuesday 15 February 2011

    Interviewee/Contributer: Ruxandra Draghia-Akli

    Organisation: European Commission

    Read more

  5. Review of oncology in 2010

    Monday 14 February 2011

    Interviewee/Contributer: Bruno Pagliara

    Organisation: On-Kos Pharma Consulting

    Read more

  6. 2011: A year of optimism and trepidation

    Thursday 10 February 2011

    Interviewee/Contributer: Robin Davison

    Organisation: Edison Investment Research

    Read more

  7. ArGEN-X builds a new antibody business

    Thursday 27 January 2011

    Interviewee/Contributer: Tim Van Hauwermeiren

    Organisation: ArGenex BV

    Read more

  8. Proposed UK 'patent box' unveiled

    Wednesday 12 January 2011

    Interviewee/Contributer: Mark Watterson

    Organisation: Simmons and Simmons LLP

    Read more

  9. EMA guidance on biosimilar monoclonal antibodies

    Wednesday 12 January 2011

    Interviewee/Contributer: Cecil Nick

    Organisation: Parexel

    Read more

  10. Launch of Takeda Ventures

    Monday 10 January 2011

    Interviewee/Contributer: Graeme Martin

    Organisation: Takeda Ventures

    Read more